Kivonat:
Although there has been considerable advancement in treatment
techniques but still there are some illnesses that continue to
exhibit a rather poor curability, such as thymoma. This report
highlights the benefit of octreotide and prednisolone therapy in
a 15-year-old girl, who was diagnosed with inoperable thymus
carcinoma, with chemotherapy and radiotherapy being the last
resort. The detection of type 2 somatostatin receptors on the
surface of the tumor justified the introduction of treatment
with somatostatin analog and prednisolone. Fortunately, after 6
months of this treatment, the tumor showed partial regression.
However, 2 months later, somatostatin receptor negative
metastases appeared; therefore, a switch over to imatinib became
essential, because the tumor was CD-117 positive. Despite the
therapy change, the patient's condition deteriorated owing to
tumor progression.